In-Vitro Diagnostics (IVD) Market Size, Share and Trends Analysis by Region, Product and Segment Forecast to 2033

In-Vitro Diagnostics (IVD) Market Size, Share and Trends Analysis by Region, Product and Segment Forecast to 2033

Summary

The In Vitro Diagnostics (IVD) market will be valued at $60.3 billion in 2023 and is expected to decline at a CAGR of -5.3% over the forecast period (2023-2033). The IVD report provides an executive-level overview of the IVD industry worldwide today, with detailed forecasts of key indicators up to 2033.

This market intelligence report offers a thorough, forward-looking analysis of the global in vitro diagnostics (IVD) market by product, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

The in vitro diagnostics market's future is bright, with technology, patient-centric care, and preventive healthcare at the forefront. This industry will continue to play a crucial role in improving healthcare outcomes and advancing medical science.​ IVD refers to medical tests conducted on samples such as blood, urine, or tissues outside the human body to diagnose various diseases and conditions.​ AI and machine learning will become integral to IVD, automating image analysis and expediting diagnosis, thereby improving workflow efficiency.

Scope

• This report provides overview and service addressable market for global in vitro diagnostics (IVD) market
• It identifies the key drivers and restraints impacting growth of the IVD market over the next 12 to 24 months.
• It includes global market forecasts for the IVD market and reimbursement scenario, and regulatory trends.
• It covers detailed segmentation by product - COVID-19 Tests, Cholesterol Tests, Colorectal Cancer Screening Tests, Hepatitis B Tests, Hepatitis C Tests, Clinical Chemistry Analyzers, Hematology Tests, Human Immunodeficiency Virus (HIV) Tests, Immunochemistry Analyzers, Diabetes Assays, and Others, along with regional segmentation.

Reasons to Buy

• This market intelligence report offers a thorough, forward-looking analysis of the global in vitro diagnostics (IVD) market by product, regional segments in a concise format to help executives build proactive and profitable growth strategies.
• Accompanying GlobalData’s Forecast products, the report examines the drivers, challenges, and regulatory trend analysis in the IVD market.
• Detailed segmentation by product - COVID-19 Tests, Cholesterol Tests, Colorectal Cancer Screening Tests, Hepatitis B Tests, Hepatitis C Tests, Clinical Chemistry Analyzers, Hematology Tests, Human Immunodeficiency Virus (HIV) Tests, Immunochemistry Analyzers, Diabetes Assays, and Others, along with vertical and regional segmentation.
• The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
• The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in IVD markets.
• The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the IVD industry which will help stakeholders analyze competition penetration.
• The broad perspective of the report, coupled with comprehensive, actionable detail, will help IVD vendors and other companies succeed in the growing IVD market globally.